Pharmaceutical Preparations · DE · CIK 1133869
Develops cell and exosome-based therapeutics for Duchenne muscular dystrophy and other diseases
Comparable business profile · signals at a glance
In the 90 days to Jun 25, 2026: 2 sold $1.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Krasney KarenEVP, GENERAL COUNSEL | Sell | 24,100 | $30.38 | $732K |
| Jun 25, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | Sell | 24,100 | $30.38 | $732K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.